Gastric Bypass In A Pill: New Angles On Diabetes Drug Development
Emerging targets are looking at diabetes/obesity crossover, as well as immunometabolic approaches that overlap with dyslipidemia.
Emerging targets are looking at diabetes/obesity crossover, as well as immunometabolic approaches that overlap with dyslipidemia.